In Vitro Study of the Polo-Like Kinase 1 Inhibitor Volasertib in Non-Small Cell Lung Cancer Reveals a Role for the Tumor Suppressor P53

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Testin Is a Tumor Suppressor in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Alterations of the Tumor Suppressor Gene Parkin in Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Involvement of a Tumor Suppressor Protein CADM1/TSLC1 in Human Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2009English

Polo-Like Kinase 1 Inhibition Diminishes Acquired Resistance to Epidermal Growth Factor Receptor Inhibition in Non-Small Cell Lung Cancer With T790M Mutations

Oncotarget
Oncology
2016English

P53 and Angiogenesis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Development of Crizotinib, a Rationally Designed Tyrosine Kinase Inhibitor for Non-Small Cell Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Targeting Polo-Like Kinase 1, a Regulator of P53, in the Treatment of Adrenocortical Carcinoma

Clinical and Translational Medicine
MedicineMolecular Medicine
2016English

Tumor Suppressor and Immediate Early Transcription Factor Genes in Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1994English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy